Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions

被引:67
作者
Arsenault, ME
Prévost, C
Lescault, A
Laberge, C
Puymirat, J
Mathieu, J
机构
[1] Neuromuscular Clin, Jonquiere, PQ G7X 7X2, Canada
[2] Ctr Sante Serv Sociaux Chicoutimi, Div Genet Counselling, Chicoutimi, PQ, Canada
[3] Ctr Hosp Univ Laval, Unit Human Genet, Laval, PQ, Canada
[4] Univ Montreal, Community Genom Med Ctr, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1212/01.wnl.0000208513.48550.08
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Myotonic dystrophy type 1 (DM1) is the most common adult form of muscular dystrophy. This autosomal dominant disorder results from an unstable cytosine, thymine, guanine (CTG) repeat expansion in the 3' untranslated region of a dystrophia myotonia protein kinase gene at 19q13.3.(1) The CTG repeat number ranges between 5 and 37 in normal subjects, whereas in DM1 patients, it is increased up to several thousands units. As a general rule, patients with larger CTG repeat expansions in their circulating leukocytes have an earlier age at onset and more severe symptoms. (2-6) Measurement of the CTG amplification is therefore considered valuable for prognostic assessment. To further improve the accuracy of prognostic assessment in predictive DNA testing of DM1, we performed a genotype-phenotype correlation study based on the clinical findings in patients carrying small CTG expansions.
引用
收藏
页码:1248 / 1250
页数:3
相关论文
共 10 条
[1]   Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts [J].
Furling, D ;
Lemieux, D ;
Taneja, K ;
Puymirat, J .
NEUROMUSCULAR DISORDERS, 2001, 11 (08) :728-735
[2]  
Gennarelli M, 1996, AM J MED GENET, V65, P342, DOI 10.1002/(SICI)1096-8628(19961111)65:4<342::AID-AJMG18>3.0.CO
[3]  
2-U
[4]   EXPANSION OF AN UNSTABLE DNA REGION AND PHENOTYPIC VARIATION IN MYOTONIC-DYSTROPHY [J].
HARLEY, HG ;
BROOK, JD ;
RUNDLE, SA ;
CROW, S ;
REARDON, W ;
BUCKLER, AJ ;
HARPER, PS ;
HOUSMAN, DE ;
SHAW, DJ .
NATURE, 1992, 355 (6360) :545-546
[5]   THE CORRELATION OF AGE OF ONSET WITH CTG TRINUCLEOTIDE REPEAT AMPLIFICATION IN MYOTONIC-DYSTROPHY [J].
HUNTER, A ;
TSILFIDIS, C ;
METTLER, G ;
JACOB, P ;
MAHADEVAN, M ;
SURH, L ;
KORNELUK, R .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (11) :774-779
[6]   MYOTONIC-DYSTROPHY - CORRELATION OF CLINICAL SYMPTOMS WITH THE SIZE OF THE CTG TRINUCLEOTIDE REPEAT [J].
JASPERT, A ;
FAHSOLD, R ;
GREHL, H ;
CLAUS, D .
JOURNAL OF NEUROLOGY, 1995, 242 (02) :99-104
[7]   Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy [J].
Marchini, C ;
Lonigro, R ;
Verriello, L ;
Pellizzari, L ;
Bergonzi, P ;
Damante, G .
CLINICAL GENETICS, 2000, 57 (01) :74-82
[8]   Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients [J].
Martorell, L ;
Monckton, DG ;
Gamez, J ;
Johnson, KJ ;
Gich, I ;
de Munain, AL ;
Baiget, M .
HUMAN MOLECULAR GENETICS, 1998, 7 (02) :307-312
[9]   Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy [J].
Mathieu, J ;
Boivin, H ;
Meunier, D ;
Gaudreault, M ;
Bégin, P .
NEUROLOGY, 2001, 56 (03) :336-340
[10]   (CTG)N TRIPLET MUTATION AND PHENOTYPE MANIFESTATIONS IN MYOTONIC-DYSTROPHY PATIENTS [J].
NOVELLI, G ;
GENNARELLI, M ;
MENEGAZZO, E ;
MOSTACCIUOLO, ML ;
PIZZUTI, A ;
FATTORINI, C ;
TESSAROLO, D ;
TOMELLERI, G ;
GIACANELLI, M ;
DANIELI, GA ;
RIZZUTO, N ;
CASKEY, CT ;
ANGELINI, C ;
DALLAPICCOLA, B .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1993, 50 (01) :85-92